Santarus Inc. Commences Patent Litigation Against Par Pharmaceutical Companies, Inc.

SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (Nasdaq:SNTS), a specialty pharmaceutical company, today announced that it has filed a lawsuit in the United States District Court for the District of Delaware against Par Pharmaceutical, Inc. for infringement of the patents listed in the Orange Book for ZEGERID® (omeprazole/sodium bicarbonate) Capsules. The University of Missouri, licensor of the patents, is joined in the litigation as a co-plaintiff.